Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 421 | 1,349 | 1,433 | 3,105 | 2,353 | 2,753 | 2,948 | 2,380 | 831 | 1,548 | | 1,034 |
% Growth | NA | 220.4% | 6.2% | 116.7% | -24.2% | 17.0% | 7.1% | -19.2% | -65.1% | 86.2% | | |
| | | | | | | | | | | | |
Cost of Revenue | (284) | (939) | (899) | (1,344) | (900) | (906) | (947) | (781) | (388) | (933) | | (669) |
Gross Profit | 137 | 411 | 534 | 1,761 | 1,454 | 1,847 | 2,001 | 1,600 | 443 | 615 | | 366 |
% Revenue | 32.5% | 30.4% | 37.3% | 56.7% | 61.8% | 67.1% | 67.9% | 67.2% | 53.3% | 39.7% | | 35.3% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3) | (19) | (35) | | (58) |
Selling and Marketing | (31) | (53) | (64) | (23) | (59) | (144) | (123) | (88) | (35) | (44) | | (37) |
General and Admin | (63) | (60) | (85) | (72) | (116) | (78) | (73) | (137) | (109) | (118) | | (152) |
Other Inc / (Exp) | (46) | (179) | (209) | (456) | (282) | (453) | (660) | (455) | (102) | (121) | | (90) |
Total Operating Exp | (140) | (292) | (357) | (551) | (457) | (674) | (856) | (683) | (265) | (318) | | (336) |
| | | | | | | | | | | | |
Operating Income | (3) | 118 | 177 | 1,210 | 997 | 1,173 | 1,145 | 917 | 179 | 297 | | 29 |
% Revenue | -0.8% | 8.8% | 12.4% | 39.0% | 42.4% | 42.6% | 38.8% | 38.5% | 21.5% | 19.2% | | 2.8% |
| | | | | | | | | | | | |
Interest Expense | 10 | (8) | (11) | 22 | 75 | 16 | 27 | 41 | 28 | 24 | | 9 |
Pre-tax Income | 7 | 110 | 166 | 1,232 | 1,072 | 1,189 | 1,172 | 957 | 207 | 321 | | 39 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (48) | (79) | (322) | (271) | (308) | (338) | (250) | (62) | (97) | | (35) |
Net Income to Company | 7 | 62 | 88 | 911 | 801 | 881 | 834 | 707 | 145 | 224 | | 3 |
% Margin | 1.7% | 4.6% | 6.1% | 29.3% | 34.0% | 32.0% | 28.3% | 29.7% | 17.5% | 14.5% | | 0.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 8 | 2 | 6 | 2 | (5) | 1 | 0 | 0 | (4) | (22) | | (21) |
Net Income to Stockholders | 15 | 64 | 94 | 913 | 796 | 882 | 834 | 708 | 142 | 203 | | (18) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 15 | 64 | 94 | 913 | 796 | 882 | 834 | 708 | 142 | 203 | | (18) |
% Margin | 3.5% | 4.7% | 6.5% | 29.4% | 33.8% | 32.0% | 28.3% | 29.7% | 17.0% | 13.1% | | -1.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.02 | 0.08 | 0.12 | 1.13 | 0.98 | 1.09 | 1.03 | 0.87 | 0.18 | 0.25 | | (0.02) |
Diluted EPS (Continuing Ops) | 0.02 | 0.08 | 0.12 | 1.13 | 0.98 | 1.09 | 1.03 | 0.87 | 0.18 | 0.25 | | (0.02) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 644.77 | 781.88 | 809.26 | 809.09 | 812.46 | 809.08 | 809.09 | 809.11 | 809.13 | 808.97 | | 808.30 |
WA Diluted Shares Out. | 644.77 | 781.88 | 809.26 | 809.09 | 812.46 | 809.08 | 809.09 | 809.11 | 809.13 | 808.97 | | 808.30 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 7 | 110 | 166 | 1,232 | 1,072 | 1,189 | 1,172 | 957 | 207 | 321 | | 39 |
Addback: Net Interest Expense | (10) | 8 | 11 | (22) | (75) | (16) | (27) | (41) | (28) | (24) | | (9) |
Addback: Other Non Operating Expenses, Total | 2 | 1 | 2 | 3 | 6 | 20 | 0 | 3 | 2 | 4 | | 4 |
Addback: Depreciation & Amortization | 8 | 9 | 10 | 11 | 12 | 11 | 12 | 11 | 12 | 17 | | 21 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 54 | 46 | 55 | 0 | 0 | 67 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (0) | (0) | 0 | (0) | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (0) | (3) | 9 | 19 | 0 | (4) | 2 | 1 | 1 | 0 | | (0) |
Adjusted EBITDA | 6 | 179 | 244 | 1,299 | 1,015 | 1,201 | 1,226 | 932 | 193 | 319 | | 54 |
% Margin | 1.5% | 13.3% | 17.0% | 41.8% | 43.1% | 43.6% | 41.6% | 39.2% | 23.2% | 20.6% | | 5.2% |
| | | | | | | | | | | | |
Adjusted EBIT | (1) | 170 | 234 | 1,288 | 1,004 | 1,190 | 1,214 | 921 | 181 | 302 | | 33 |
% Margin | -0.3% | 12.6% | 16.3% | 41.5% | 42.6% | 43.2% | 41.2% | 38.7% | 21.8% | 19.5% | | 3.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 7 | 62 | 88 | 911 | 801 | 881 | 834 | 707 | 145 | 224 | | 3 |
Addback: Unusual Items | (0) | 51 | 55 | 74 | 1 | (4) | 69 | 1 | 1 | 1 | | (0) |
Less: Tax Benefit of Unusual Items (26%) | 0 | (13) | (14) | (19) | (0) | 1 | (18) | (0) | (0) | (0) | | 0 |
Adjusted Net Income | 7 | 99 | 129 | 965 | 802 | 879 | 885 | 708 | 146 | 225 | | 3 |
% Margin | 1.6% | 7.4% | 9.0% | 31.1% | 34.1% | 31.9% | 30.0% | 29.8% | 17.5% | 14.5% | | 0.3% |